Wolffian duct cell tumor


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Wolffian duct cell tumor is a little studied and rarely found neoplasm. No more than 100 cases of this tumor have been described in the world literature. The tumor develops due to disorders in the process of embryogenesis. In the female fetus, the Wolffian ducts are known to undergo involution, whereas the low level of anti-Mullerian hormone allows the Mullerian duct to develop. However, when differentiation of female genital organs is impaired, the fetus develops neoplasms from the rudiments of the Wolffian duct. According to the WHO Classification of Tumors of Female Reproductive Organs, the neoplasm is presently called Wolffian duct cell tumor and is generally detected in the broad ligament of the uterus, fallopian tubes, mesosalpinx, and ovary. There have been single case reports of retroperitoneal Wolffian duct cell tumor in the lateral channel of the abdominal cavity. There are no clinical practice guidelines for the treatment of Wolffian duct cell tumor; therefore, a description of clinical cases of this rare tumor is of interest. Case report. This paper describes a clinical case of a tumor of Wolffian origin concurrent with stage IB1 cervical cancer in a 45-year-old woman. It shows the features of clinical and instrumental examinations. A morphological study plays a key role in the diagnosis of an ovarian tumor. An immunohistochemical study is a specified diagnostic method, which reveals no expression with antibodies to Inhibin, Vimentin, Calretinin, Chromogranin, CD-99, CD-10, WT-1, and estrogen receptors. The tumor cells focally expressed SK-7, EMA, andp-53, which suggested that the tumors of Wolffian origin are immunologically non-specific. The data available in the literature show that no expression with anti-CD-56 antibodies may indicate the benign course of the tumor. Conclusion. The clinical case under discussion shows that in the morphological pattern of the tumor, there are no necrotic areas or signs of invasive growth into the capsule; a low mitotic activity was found. In this connection, the tumor was regarded as apparently benign. It is recommended that the patient be followed up.

Full Text

Restricted Access

About the authors

Maria A. Meshkova

P.A.Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia

Email: mari.meshkova.95@mail.ru
Clinical Resident of l-st year

Svetlana V. Mukhtarulina

P.A.Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia

Email: svmukhtarulina@yandex.ru
PhD, Head of the Oncogynecology department

Natalia S. Goeva

P.A.Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia

Email: natalia.lisago@yandex.ru
pathologist of the Pathologic department

Nadezhda N. Volchenko

P.A.Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia

Email: mnioi_morphology@mail.ru
MD, professor, Head of the Department of oncomorphology

Elena G. Novikova

P.A.Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia

Email: egnov@bk.ru
PhD, professor, Honoured Science Worker of Russian Federation, Deputy Head of the Oncogynecology department

Natalia A. Rubtsova

P.A.Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia

Email: rnal7@yandex.ru
PhD, Head of the Radiation diagnostics department

Alexandr N. Vostrov

P.A.Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia

Email: alexander-v65@yandex.ru
cms, senior research specialist of the Department of Ultrasound diagnostics

References

  1. Karminejad M., Scully R. Female adnexal tumor of probable Wolffian origin: a distinct pathologic entity. Cancer. 1973; 31(3): 671-7.
  2. Rosen С., Reardon E., Shyu S., Terhune J., Saats P., Ioffe O., Kavic S. Wolffian tumor (female adnexal tumor of Wolffian origin) presenting as a pelvic side wall mass: Report of a case. SAGE Open Med. Case Rep. 2019; 7: 2050313X19839534. https://dx.doi.org/10.1177/2050313X19839534.
  3. Liu L., Fang Q., Xing Y. Female adnexal tumor of probable Wolffian origin arising from mesosalpinx: A case report and review. J. Obstet. Gynaecol. Res. 2018; 44(9): 1859-63. https://dx.doi.org/10.1111/jog.13704.
  4. Hong S., Cui J., Li L., Buscema J., Liggins C., Zheng W. Malignant female adnexal tumor of probable Wolffian origin: case report and literature review. Int. J. Gynecol. Pathol. 2018; 37(4): 331-7. https://dx.doi.org/10.1097/ PGP.0000000000000422.
  5. Дубова Е.А., Павлов К.А., Лищук С.В., Тертычный А.С., Бахвалова А.А., Брюнин Д.В. Опухоль из клеток вольфова протока: клиническое наблюдение и обзор литературы Альманах клинической медицины. 2018; 46(4): 374-8. [Dubova E.A., Pavlov K.A., Lishchuk S.V., Tertychnyi A.S., Bakhvalova A.A., Bryunin D.V. Wollfian tumor: a case report and a literature review. Almanac of Clinical Medicine. 2018; 46(4): 374-8. (in Russian)]. https://dx.doi.org/10.18786/2072-0505-2018-46-4-374-378.
  6. Qiu T., Teng Y., Tong J., Tao W., Xu L. Recurrent female adnexal tumor of probably Wolffian origin: A case report. Taiwan. J. Obstet. Gynecol. 2017; 56(3): 382-4. https://dx.doi.org/10.1016/j.tjog.2016.12.017.
  7. Cossu A., Casula M., Paliogiannis P., Tanda F., Palomba G., Sini M.C. et al. Female Adnexal Tumors of Probable Wolffian origin (FATWO): a case series with next-generation sequencing mutation analysis. Int. J. Gynecol. Pathol. 2017; 36(6): 575-81. https://dx.doi.org/10.1097/PGP.0000000000000368.
  8. Moro F., Pozzati F., Di Legge A., De Blasis I., Scambia G., Testa A.C. Adnexal tumor of probable Wolffian origin arising from retroperitoneal space. Ultrasound Obstet. Gynecol. 2017; 49(6): 807-8. https://dx.doi.org/10.1002/ uog.17226.
  9. Kwon M.J., Yun M.J., Kim M.K. A female adnexal tumor of probable Wolffian origin showing positive O-6-methylguanine-DNA methyltransferase methylation. Obstet. Gynecol. Sci. 2016; 59(4): 328-32. https://dx.doi. org/10.5468/ogs.2016.59.4.328.
  10. Nann D., Gahlen S., Keul H.G., Voigt H.J., Fend F., Staebler A. Tumor of the mesosalpinx with unclear differentiation. Pathologe. 2016; 37(1): 84-7. https:// dx.doi.org/10.1007/s00292-015-0128-6.
  11. Gupta A.K., Srinivasan R., Nijhawan R. Female adnexal tumor of probable Wolffian origin. Indian J. Pathol. Microbiol. 2014; 57(4): 620-2. https://dx.doi. org/10.4103/0377-4929.142703.
  12. Liu R.Q., Zhang Z.H., Pan M.H., Zhang Z.H., Fan Q.H. Wolffian adnexal tumor: report of a case. Zhonghua Bing Li Xue Za Zhi. 2013; 42(7): 476-7.
  13. Rey R., Picard J.Y. Embryology and endocrinology of genital development. Baillieres Clin. Endocrinol. Metab. 1998; 12(1): 17-33.
  14. Kurman R.J., Carcangiu M.L., Herrington C.S., Young R.H., eds. WHO Classification of tumours of female reproductive organs. Revised 4th ed. Lyon: IARC Press; 2014. 312p.
  15. Tavassoli FA., Devilee P., eds. World Health Organization Classification of tumors. Pathology and genetics of tumours of the breast and family genital organs. Lyon: IARC Press; 2003: 212-3.
  16. Brocard H., Renault P., Grivaux M., Pichard R. Malignant retroperitoneal tumor of the wolffian epithelioma type. Sem. Hop. 1950; 26(72): 3773-6.
  17. Heatley M.K. Is female adnexal tumour of probable wolffian origin a benign lesion? A systematic review of the English literature. Pathology. 2009; 41(7): 645-8. https://dx.doi.org/10.3109/00313020903273084.
  18. Hong S., Cui J., Li L., Buscema J., Liggins C., Zheng W. Malignant female adnexal tumor of probable Wolffian origin: case report and literature review. Int. J. Gynecol. Pathol. 2018; 37(4): 331-7. https://dx.doi.org/10.1097/ PGP.0000000000000422.
  19. Heller D.S., Kadire B., Cracchiolo B. Malignant female adnexal tumor of probable Wolffian origin: a case report. J. Reprod. Med. 2011; 56(3): 175-7.
  20. Liu Y. Metastatic female adnexal tumor of possible wolffian origin (FATWO) of the appendix demonstrated by FDG PET/CT: the first reported case. Clin. Nucl. Med. 2011; 36(2): 136-7. https://dx.doi.org/10.1097/RLU.0b013e318203bc77.
  21. Hockel M. Total mesometrial resection - Author’s reply. Lancet Oncol. 2005; 6(12): 919-20. https://dx.doi.org/10.1016/S1470-2045(05)70441-1.
  22. Steed H., Oza A., Chapman W.B., Yaron M., De Petrillo D. Female adnexal tumor of probable wolffian origin: a clinicopathological case report and a possible new treatment. Int J Gynecol Cancer. 2004; 14(3): 546-50.
  23. Sakai K., Abiko N., Kondoh E., Yamaguchi K., Minamiguchi S. Two cases of Wolffian tumor with novel magnetic resonance imaging findings reflecting characteristic pathology. J Obstet Gynaecol Res. 2016; 42: 1046-51.
  24. Mathevon J. Metastatic development of a wolffian tumor of the ovary; seminoma of the ovary with survival for more than five years. Lyon Chir. 1951; 46(6): 759-61.
  25. Colson P. Wolffian tumor of the ovary; uterine and vaginal metastases. Lyon Chir. 1950; 45(6): 752-3.
  26. Sivridis E., Giatromanolaki A., Koutlaki N., Anastasiadis P. Malignant female adnexal tumor of probable Wolffian origin: criteria of malignancy. Histopathology. 2005; 46(6): 716-8. https://dx.doi.org/10.1111/j.1365-2559.2005.02035.x.
  27. Nakayama K., Miura H., Fujiwaki R., Manabe A. Malignant female adnexal tumor of Wolffian origin (FATWO) positive for CD56: a possible diagnostic role for the biomarker. Eur. J. Gynaecol. Oncol. 2014; 35(5): 580-3.
  28. Wakayama A., Matsumoto H., Aoyama H., Saio M., Kumagai A., Ooyama T., Inamine M., Aoki Y. Recurrent female adnexal tumor of probable Wolffian origin treated with debulking surgery, imatinib and paclitaxel/carboplatin combination chemotherapy: A case report. Oncol. Lett. 2017; 13(5): 3403-8. https://dx.doi.org/10.3892/ol.2017.5874.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2020 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies